Uterine leiomyosarcoma and disseminated peritoneal leiomyomatosis in the surgical treatment of uterine myoma: a retrospective analysis
- 作者: Seregin A.A.1, Kosova Y.A.2, Seregina P.A.3, Ponomareva Y.N.1, Nadezhdenskaia A.B.4, Kirilova E.V.1, Asaturova A.V.1, Tregubova A.V.1, Magnaeva A.S.1, Ishchuk M.P.1, Ovodenko D.L.1
-
隶属关系:
- Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
- Yevdokimov Moscow State University of Medicine and Dentistry
- Sechenov First Moscow State Medical University (Sechenov University)
- Astrakhan State Medical University
- 期: 卷 24, 编号 5 (2022)
- 页面: 386-392
- 栏目: ORIGINAL ARTICLE
- URL: https://journal-vniispk.ru/2079-5831/article/view/110811
- DOI: https://doi.org/10.26442/20795696.2022.5.201860
- ID: 110811
如何引用文章
全文:
详细
Aim. To analyze the incidence and types of adverse outcomes and complications of laparoscopic myomectomies.
Materials and methods. This work is a retrospective study based on data from the Kulakov National Medical Research Center for Obstetrics, Gynecology, and Perinatology. We analyzed 711 case histories of patients diagnosed with uterine myoma who received surgical treatment in the Department of Innovative Oncology and Gynecology from 2015 to 2019. The frequency of malignant neoplasms, verified by pathomorphological examination, and the characteristics of surgical interventions performed in these patients were comparatively evaluated.
Results. Surgical interventions for uterine myoma are leading in gynecology due to the high prevalence of such disorders. Conservative myomectomy remains the "gold standard" in organ-sparing surgery. However, during surgeries for suspected benign neoplasms, there is a risk of morcellation of the malignant tumor, significantly worsening patient survival outcomes. In our study, the incidence of uterine leiomyosarcoma in suspected benign neoplasms was 0.98%. The probability of parasitic myomas or disseminated perineal leiomyomatosis after myomatous nodule morcellation is 0.19%.
Conclusion. No reliable information about the malignant potential of the tumor and its proliferative activity can be obtained until a definitive pathomorphological examination. The above considerations warrant the routine use of prophylactic measures to prevent tumor cell dissemination.
作者简介
Alexander Seregin
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
编辑信件的主要联系方式.
Email: ggk32@ya.ru
ORCID iD: 0000-0001-5236-3194
Cand. Sci. (Med.)
俄罗斯联邦, MoscowYana Kosova
Yevdokimov Moscow State University of Medicine and Dentistry
Email: Yana_kosova@icloud.com
ORCID iD: 0000-0002-4803-2541
Student
俄罗斯联邦, MoscowPolina Seregina
Sechenov First Moscow State Medical University (Sechenov University)
Email: Seregina_04@list.ru
ORCID iD: 0000-0001-6149-6212
Student
俄罗斯联邦, MoscowYulia Ponomareva
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Email: juliyapon@mail.ru
ORCID iD: 0000-0001-9888-4219
D. Sci. (Med.), Prof.
俄罗斯联邦, MoscowAnastasiia Nadezhdenskaia
Astrakhan State Medical University
Email: Nastraliana@gmail.com
ORCID iD: 0000-0003-0782-5112
Medical Resident
俄罗斯联邦, AstrakhanEleonora Kirilova
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Email: kirilova.ellie@gmail.com
ORCID iD: 0000-0002-2793-9814
Graduate Student
俄罗斯联邦, MoscowAleksandra Asaturova
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Email: a_asaturova@oparina4.ru
ORCID iD: 0000-0001-8739-5209
D. Sci. (Med.)
俄罗斯联邦, MoscowAnna Tregubova
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Email: annyupitrue@mail.ru
ORCID iD: 0000-0003-4601-1330
pathologist
俄罗斯联邦, MoscowAlina Magnaeva
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Email: a_magnaeva@oparina4.ru
ORCID iD: 0000-0001-5223-9767
pathologist
俄罗斯联邦, MoscowMaria Ishchuk
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Email: marumariyaish@gmail.com
ORCID iD: 0000-0002-9577-1777
Medical Resident
俄罗斯联邦, MoscowDmitry Ovodenko
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Email: d_ovodenko@oparina4.ru
ORCID iD: 0000-0003-0700-8374
D. Sci. (Med.)
俄罗斯联邦, Moscow参考
- Адамян Л., Андреева Е., Артымук Н. Миома матки: диагностика, лечение и реабилитация. Клинические рекомендации (протокол лечения). 2015. Режим доступа: https://moniiag.ru/wp-content/uploads/2018/03/Mioma-matki-diagnostika-lechenie-i-reabilitatsiya.pdf. Ссылка активна на 24.08.2022 [Adamian L, Andreeva E, Artymuk N, et al. Mioma matki: diagnostika, lechenie i reabilitatsiia. Klinicheskie rekomendatsii (protokol lecheniia). 2015. Available at: https://moniiag.ru/wp-content/uploads/2018/03/Mioma-matki-diagnostika-lechenie-i-reabilitatsiya.pdf. Accessed: 24.08.2022 (in Russian)].
- Lurie S, Piper I, Woliovitch I, Glezerman M. Age-related prevalence of sonographicaly confirmed uterine myomas. J Obstet Gynaecol. 2005;25(1):42-4. doi: 10.1080/01443610400024583
- Lurie S, Piper I, Woliovitch I, Glezerman M. Age-related prevalence of sonographicaly confirmed uterine myomas. J Obstet Gynaecol. 2005;25(1):42-4. doi: 10.1080/01443610400024583
- Gofur NRP. Uterine Myoma, Risk Factor and Pathophysiology: A Review Article. Clin Onco. 2021;4(3):1-4.
- Вихляева Е.М. Руководство по диагностике и лечению лейомиомы матки. М.: МЕДпресс-информ, 2004 [Vikhliaeva EM. Rukovodstvo po diagnostike i lecheniiu leiomiomy matki. Moscow: MEDpress-inform, 2004 (in Russian)].
- Palmer R. Instrumentation and technique of gynecological laparoscopy. Gynecol Obstet (Paris). 1947;46(4):420-31.
- Bhave Chittawar P, Franik S, Pouwer AW, Farquhar C. Minimally invasive surgical techniques versus open myomectomy for uterine fibroids. Cochrane Database Syst Rev. 2014;(10):CD004638. doi: 10.1002/14651858.CD004638.pub3
- Gil Y, Badeghiesh A, Suarthana E, et al. Risk of uterine rupture after myomectomy by laparoscopy or laparotomy. J Gynecol Obstet Hum Reprod. 2020;49(8):101843. doi: 10.1016/j.jogoh.2020.101843
- Александров М.С. Хирургическое лечение фибромиом матки. М.: Медгиз, 1958 [Aleksandrov MS. Khirurgicheskoe lechenie fibromiom matki. Moscow: Medgiz, 1958 (in Russian)].
- Кулаков В.И., Адамян Л.В. Реконструктивная хирургия в гинекологии. Акушерство и гинекология. 1994;4:51-7 [Kulakov VI, Adamian LV. Rekonstruktivnaia khirurgiia v ginekologii. Akusherstvo i ginekologiia. 1994;4:51-7 (in Russian)].
- Marret H, Chevillot M, Giraudeau B; Study Group of the French Society of Gynaecology and Obstetrics (Ouest Division). Factors influencing laparoconversions during the learning curve of laparoscopic myomectomy. Acta Obstetricia Gynecol Scand. 2006;85(3):324-9. doi: 10.1080/00016340500438165
- Uzunlar O, Ibanoglu MC, Kaplan A. Technique to reduce blood loss during open abdominal myomectomy: transverse or vertical incision? Rev Assoc Med Bras. 2021;67(3):426-30. doi: 10.1590/1806-9282.20200880
- Kumakiri J, Takeuchi H, Itoh S, et al. Prospective Evaluation for the Feasibility and Safety of Vaginal Birth after Laparoscopic Myomectomy. J Minim Invasive Gynecol. 2008;15(4):420-4. doi: 10.1016/j.jmig.2008.04.008
- Миннуллина Ф.Ф., Мухаметзянова Л.М., Ахметшина Л.Р. Консервативная миомэктомия во время беременности. Norwegian Journal of Development of the International Science. 2021;58-1:27-31 [Minnullina FF, Mukhametzyanova LM, Ahmetshina LR. Myomectomy in pregnancy. Norwegian Journal of Development of the International Science. 2021;58-1:27-31 (in Russian)]. doi: 10.24412/3453-9875-2021-58-1-27-31
- Петракова C.А., Буянова С.Н., Мгелиашвили М.В. Возможности миомэктомии в коррекции репродуктивного здоровья женщин с миомой матки. Российский вестник акушера-гинеколога. 2009;1:30-5 [Petrakova CA, Buianova SN, Mgeliashvili MV. Vozmozhnosti miomektomii v korrektsii reproduktivnogo zdorov'ia zhenshchin s miomoi matki. Rossiiskii vestnik akushera-ginekologa. 2009;1:30-5 (in Russian)].
- Зязева И.П., Ощепкова С.Ю. Современные аспекты консервативной миомэктомии. Международный студенческий научный вестник. 2021;1:24 [Ziazeva IP, Oshchepkova SIu. Sovremennye aspekty konservativnoi miomektomii. Mezhdunarodnyi studencheskii nauchnyi vestnik. 2021;1:24 (in Russian)].
- Туксанова Д.И., Негматуллаева М.Н., Ахмедов Ф.К., Бобокулова С.Б. Консервативная миомэктомия у женщин репродуктивного возраста. Университетская наука: взгляд в будущее. 2020:609-12 [Tuksanova DI, Negmatullaeva MN, Akhmedov FK, Bobokulova SB. Konservativnaia miomektomiia u zhenshchin reproduktivnogo vozrasta. Universitetskaia nauka: vzgliad v budushchee. 2020:609-12 (in Russian)].
- Fujimoto A, Morimoto C, Hosokawa Y, Hasegawa A. Suturing method as a factor for uterine vascularity after laparoscopic myomectomy. Eur J Obstet Gynecol Reprod Biol. 2017;211:146-9. doi: 10.1016/j.ejogrb.2017.02.027
- Glasser MH. Minilaparotomy myomectomy: A minimally invasive alternative for the large fibroid uterus. J Minim Invasive Gynecol. 2005;12(3):275-83. doi: 10.1016/j.jmig.2005.03.009
- Benedetti-Panici P, Maneschi F, Cutillo G, et al. Surgery by minilaparotomy in benign gynecologic disease. Obstet Gynecol. 1996;87(3):456-9. doi: 10.1016/0029-7844(95)00441-6
- Bhave Chittawar P, Franik S, Pouwer AW, Farquhar C. Minimally invasive surgical techniques versus open myomectomy for uterine fibroids. Cochrane Database Syst Rev. 2014;(10):CD004638. doi: 10.1002/14651858.CD004638.pub3
- Nugent W, Engelke G, Reicke S, et al. Laparoscopic supracervical hysterectomy or myomectomy with power morcellation: risk of uterine leiomyosarcomas. A retrospective trial including 35.161 women in Germany. J Minim Invasive Gynecol. 2015;22(6s):S2-3. doi: 10.1016/j.jmig.2015.08.013
- Oduyebo T, Hinchcliff E, Meserve EE, et al. Risk factors for occult uterine sarcoma among women undergoing minimally invasive gynecologic surgery. J Minim Invasive Gynecol. 2016;23(1):34-9. doi: 10.1016/j.jmig.2015.07.017
- Rodriguez AM, Zeybek B, Asoglu MR, et al. Incidence of occult leiomyosarcoma in presumed morcellation cases: a database study. Eur J Obstet Gynecol Reprod Biol. 2016;197:31-5. doi: 10.1016/j.ejogrb.2015.11.009
- Lieng M, Berner E, Busund B. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women. J Minim Invasive Gynecol. 2015;22(3):410-4. doi: 10.1016/j.jmig.2014.10.022
- Kade G, Spaleniak S, Frankowska E, et al. Disseminated peritoneal leiomyomatosis – a rare complication of laparoscopic myomectomy with intraperitoneal morcellation. OncoReview. 2020;10(3):113-6. doi: 10.24292/01.OR.320290920
- Park BY, Leslie KO, Chen L, et al. A case of simultaneous benign metastasizing leiomyomas and disseminated peritoneal leiomyomatosis following endoscopic power morcellation for uterine disease. Female Pelvic Med Reconstr Surg. 2017;23(1):e1-3. doi: 10.1097/SPV.0000000000000342
- Nguyen D, Maheshwary R, Tran C, et al. Diffuse peritoneal leiomyomatosis status post laparoscopic hysterectomy with power morcellation: a case report with review of literature. Gynecol Oncol Rep. 2017;19:59-61. doi: 10.1016/j.gore.2017.01.001
- Cucinella G, Granese R, Calagna G, et al. Parasitic myomas after laparoscopic surgery: an emerging complication in the use of morcellator? Description of four cases. Fertil Steril. 2011;96(2):e90-6. doi: 10.1016/j.fertnstert.2011.05.095
- Leren V, Langebrekke A, Qvigstad E. Parasitic leiomyomas after laparoscopic surgery with morcellation. Acta Obstet Gynecol Scand. 2012;91(10):1233-6. doi: 10.1111/j.1600-0412.2012.01453.x
- Donnez O, Squifflet J, Leconte I, et al. Posthysterectomy pelvic adenomyotic masses observed in 8 cases out of a series of 1405 laparoscopic subtotal hysterectomies. J Minim Invasive Gynecol. 2007;14(2):156-60. doi: 10.1016/j.jmig.2006.09.008
补充文件
